ASBP - Aspire Biopharma Holdings, Inc. Common Stock
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 0.34 0.01 (2.98%) | --- | 0.0 (0.06%) | 0.01 (2.62%) | 0.01 (2.8%) | 0.01 (2.46%) | 0.01 (2.62%) | 0.01 (2.62%) |
Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
AfterHours
Earnings & Ratios
- Basic EPS:
- Diluted EPS:
- Basic P/E:
- Diluted P/E:
- RSI(14) 1m:
- 49.26
- VWAP:
- 0.35
- RVol:
- 0.0691
Events
| Period | Kind | Movement | Occurred At |
|---|---|---|---|
| 1m | Price increase 1m | 0.35 +0.01 (+1.99%) | Oct 15 16:43 |
| 1m | Price decrease 1m | 0.34 -0.01 (-1.97%) | Oct 15 16:33 |
| 1m | Price increase 1m | 0.35 +0.01 (+1.69%) | Oct 15 15:59 |
| 1m | Price increase 1m | 0.35 +0.0 (+1.16%) | Oct 15 15:47 |
| 1m | Price increase 1m | 0.34 +0.0 (+1.34%) | Oct 15 15:18 |